A major study of nearly 2 million heart attack patients has found that many who also had cancer were not offered a potentially lifesaving treatment, despite the fact it had major benefits.
The international research team, led by Keele’s Professor Mamas Mamas and the Keele Cardiovascular Research Group, analyzed data from 1.8 million patients who presented with a ST-elevation myocardial infarction (STEMI) – a type of heart attack -to investigate whether patients who also have cancer gain as much benefit from receiving a treatment called Percutaneous Coronary Intervention, as those without cancer during their heart attack.
